Regulators with Health Canada and Switzerland's Swissmedic are lifting their respective bans on Novartis' trivalent flu vaccines Agrippal and Fluad after independent testing found them to be safe for ...
The commercial success of Bexsero — the vaccine made by Swiss pharmaceutical company Novartis that will be offered to Princeton students in December and is not yet licensed for use in the United ...
Italy's Agenxia Italiana del Farmaco (AIFA) has joined Canadian and Swiss regulators in affirming the safety of Novartis' Agrippal (alternately known as Agriflu) and Fluad after concerns were raised ...
Italian, Swiss and Austrian authorities on Wednesday halted the sale of flu vaccines made by Swiss pharmaceutical giant Novartis. The Italian health ministry said it has banned the sale and use of ...
Pharmalittle: We’re reading about a memo on RFK Jr., a Novartis blockbuster’s failed trial, and more
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...
And Finally... Portland State University virologists discovered how to neutralize viruses by coating them in silica and then bring them back to life by removing the coat--the team dubbed them "zombie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results